Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study - Related Studies

Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study

This study has been completed.

Study NCT00053599. Last updated on February 19, 2008. Information provided by National Institute on Aging (NIA)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Alzheimer Disease

2	More general conditions related to this trial
		Brain Diseases
		Central Nervous System Diseases
		Delirium, Dementia, Amnestic, Cognitive Disorders
		Dementia
		Mental Disorders
		Nervous System Diseases
		Neurodegenerative Diseases
		Tauopathies

3	Interventions listed in this trial
		Simvastatin

4	More general drug interventions related to this trial
		Anticholesteremic Agents
		Antilipemic Agents
		Antimetabolites
		Enzyme Inhibitors
		Hydroxymethylglutaryl-CoA Reductase Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

5	Sponsors listed in this trial
		National Institute on Aging (NIA)